- Home
- MNTK vs ARCT Comparison
MNTK vs ARCT Comparison
Compare MNTK & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNTK
- ARCT
- Stock Information
- Founded
- MNTK 1980
- ARCT 2013
- Country
- MNTK United States
- ARCT United States
- Employees
- MNTK N/A
- ARCT N/A
- Industry
- MNTK Natural Gas Distribution
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- MNTK Utilities
- ARCT Health Care
- Exchange
- MNTK Nasdaq
- ARCT Nasdaq
- Market Cap
- MNTK 622.2M
- ARCT 487.0M
- IPO Year
- MNTK 2021
- ARCT N/A
- Fundamental
- Price
- MNTK $4.49
- ARCT $16.41
- Analyst Decision
- MNTK Hold
- ARCT Strong Buy
- Analyst Count
- MNTK 2
- ARCT 7
- Target Price
- MNTK $6.00
- ARCT $65.00
- AVG Volume (30 Days)
- MNTK 188.3K
- ARCT 375.2K
- Earning Date
- MNTK 03-13-2025
- ARCT 03-06-2025
- Dividend Yield
- MNTK N/A
- ARCT N/A
- EPS Growth
- MNTK 42.11
- ARCT N/A
- EPS
- MNTK 0.16
- ARCT N/A
- Revenue
- MNTK $194,849,000.00
- ARCT $160,399,000.00
- Revenue This Year
- MNTK $21.28
- ARCT $7.33
- Revenue Next Year
- MNTK $31.59
- ARCT $4.71
- P/E Ratio
- MNTK $27.76
- ARCT N/A
- Revenue Growth
- MNTK 9.63
- ARCT N/A
- 52 Week Low
- MNTK $3.38
- ARCT $14.30
- 52 Week High
- MNTK $7.83
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- MNTK 57.18
- ARCT 44.15
- Support Level
- MNTK $4.08
- ARCT $16.07
- Resistance Level
- MNTK $4.24
- ARCT $17.51
- Average True Range (ATR)
- MNTK 0.26
- ARCT 1.36
- MACD
- MNTK 0.04
- ARCT -0.11
- Stochastic Oscillator
- MNTK 58.22
- ARCT 7.62
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a United States-based renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments: Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.